What is included in a multimodal approach to interstitial cystitis (IC) therapy?
When treating patients with IC, clinicians should consider that both pharmacologic and nonpharmacologic therapy may be needed for optimal symptom control. ELMIRON ® is the only FDA-approved oral agent indicated for bladder pain or discomfort associated with IC and is recommended as the foundation of IC therapy. Dimethyl sulfoxide, an intravesical instillation, is the only FDA-approved intravesical therapy indicated for IC.
Related Questions
- I have all the symptoms of Interstitial Cystitis, but following biopsies I have been told that I do not have IC. How accurate are biopsies in assisting the diagnosis of the condition?
- What is Interstitial Cystitis (IC) or Painful Bladder Syndrome (PBS)?
- What is interstitial cystitis/painful bladder syndrome (IC/PBS)?
